Comments

Intellia Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NTLANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$9.14

-0.08-0.87%

At close: -

$9.18

0.040.44%

After Hours: Mar 14, 6:48 PM EDT

Intellia Therapeutics (NTLA) Forecast

News Earnings Intellia Therapeutics (NTLA) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Intellia Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:NTLA | Benzinga

Explore Intellia Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NTLA.

Open	$9.17
Close	$9.14
Volume / Avg.	2.06M / 3.14M
Day Range	$8.97 - $9.60
52 Wk Range	8.30 - 28.88
Market Cap	$950.29M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	28.58%
Days to Cover	6.07

Recent News

Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.

Rounak Jain

This RingCentral Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$9.17
Close	$9.14
Volume / Avg.	2.06M / 3.14M
Day Range	$8.97 - $9.60
52 Wk Range	8.30 - 28.88
Market Cap	$950.29M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	28.58%
Days to Cover	6.07

About Intellia Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based ther...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Intellia Therapeutics (NTLA) stock?

You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.

View our list of the best stock brokerages

Who are Intellia Therapeutics (NTLA) competitors?

Other companies in Intellia Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?

Intellia Therapeutics has a consensus price target of $49.50.

What is the current price for Intellia Therapeutics (NTLA)?

The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $9.18 last updated March 14, 2025 at 6:48 PM EDT.

Does Intellia Therapeutics (NTLA) pay a dividend?

There are no upcoming dividends for Intellia Therapeutics.

When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?

Intellia Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Intellia Therapeutics (NTLA) going to split?

There is no upcoming split for Intellia Therapeutics.

What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.